Jessica Hou joined 1315 Capital as a Partner in 2022, bringing nine years of healthcare growth-stage investing. See sector focus and contact routes.
Jessica Hou joined 1315 Capital as a Partner in 2022, bringing nine years of healthcare growth-stage investing experience from her prior role as Managing Director at Montreux Growth Partners. Her investment focus centers on early to mid-stage healthcare companies, specifically within pharma, medtech, health technology, services, specialty pharmaceuticals, biopharmaceuticals, medical devices, diagnostics, and consumer healthcare. While specific check sizes and lead/follow behavior are not publicly detailed, 1315 Capital raises funds exceeding $300 million for its second fund to support these pharma and medtech investments. Hou’s notable portfolio includes board seats at NutriSense and Colorescience, a co-investment between Montreux and 1315 Capital, alongside past board roles at FinPay, SI-BONE, and Tobira Therapeutics. She has contributed to policy and research initiatives with the Medical Innovation and Competitiveness Coalition and the National Venture Capital Association, reflecting a commitment to broader healthcare innovation ecosystems. Hou holds a BA in Human Biology and English from Stanford University and an MBA from Stanford Graduate School of Busin
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Philadelphia.
Investors like Jessica Hou · Full investor directory · Investor access · Company funding database